Unique ID issued by UMIN | UMIN000058354 |
---|---|
Receipt number | R000066671 |
Scientific Title | Effects of Ingestion of Lactic Acid Bacteria on Subjective Physical Symptoms in Children: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparison Study. |
Date of disclosure of the study information | 2025/07/03 |
Last modified on | 2025/07/02 15:43:03 |
Effects of Ingestion of Lactic Acid Bacteria on Subjective Physical Symptoms in Children: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparison Study.
Effects of Ingestion of Lactic Acid Bacteria on Subjective Physical Symptoms in Children.
Effects of Ingestion of Lactic Acid Bacteria on Subjective Physical Symptoms in Children: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparison Study.
Effects of Ingestion of Lactic Acid Bacteria on Subjective Physical Symptoms in Children.
Japan |
Healthy children
Not applicable | Child |
Others
NO
To prove benefits of lactic acid bacteria intake on cold symptoms in healthy children.
Safety,Efficacy
Number of days and duration of cold symptoms
Number of fever days
Number of vomiting
Number of days of antibiotics use
Number of days absent from nursery school or kindergarten
Number of days and duration of diarrhea
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
Food |
Daily ingestion of powdered lactic acid bacteria for 24 weeks.
Daily ingestion of placebo powder for 24 weeks.
2 | years-old | <= |
6 | years-old | > |
Male and Female
1. Subjects who are between the ages of 2 and 5 years old.
2. Subjects whose parents agree to participate in this study with a written informed consent.
1. Subjects with serious hepatic, renal, cardiac, lung, gastrointestinal, blood, brain, endocrine or metabolic diseases, and/or with serious medical history of those disease.
2. Subjects who regularly use oral or nasal medications.
3. Subjects who regularly use steroids.
4. Subjects who regularly take foods that affect immune function.
5. Subjects with severe perennial and/or seasonal allergic symptoms.
6. Subjects at risk of allergic reactions to drugs or foods.
7. Subjects who participated in clinical studies of other drugs and foods within the last 4 weeks prior to the current study.
8. Subjects who are deemed ineligible by the principal investigator.
200
1st name | Jun |
Middle name | |
Last name | NISHIHIRA |
Hokkaido Information University
Department of Medical Management and Informatics
069-8585
59-2, Nishi-nopporo, Ebetsu, Hokkaido, 069-8585, Japan
011-385-4430
hisc-acad.res@s.do-johodai.ac.jp
1st name | Naoyuki |
Middle name | |
Last name | HONMA |
Hokkaido Information University
Health Information Science Center
069-8585
59-2, Nishi-nopporo, Ebetsu, Hokkaido, 069-8585, Japan
011-385-4430
hisc-acad.res@s.do-johodai.ac.jp
Hokkaido Information University
Morinaga Milk Industry Co., Ltd.
Profit organization
Japan
The ethics committee of Hokkaido Information University
59-2, Nishi-nopporo, Ebetsu, Hokkaido, 069-8585, Japan
011-385-4411
soumu@do-johodai.ac.jp
NO
北海道情報大学 保健センター(北海道)
2025 | Year | 07 | Month | 03 | Day |
Unpublished
Preinitiation
2025 | Year | 06 | Month | 19 | Day |
2025 | Year | 06 | Month | 19 | Day |
2025 | Year | 07 | Month | 04 | Day |
2026 | Year | 05 | Month | 31 | Day |
2025 | Year | 07 | Month | 03 | Day |
2025 | Year | 07 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066671